TI
MBIO icon

Telemetry Investments’s Mustang Bio MBIO Stock Holding History

Telemetry Investments’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$155K Sell
524
-79
-13% -$27K 0.36% 79
2022
Q3 		$212K Buy
603
+23
+4% +$10.7K 0.35% 95
2022
Q2 		$254K Buy
580
+183
+46% +$101K 0.39% 90
2022
Q1 		$300K Buy
397
+170
+75% +$140K 0.48% 75
2021
Q4 		$282K Buy
227
+60
+36% +$96.9K 0.37% 95
2021
Q3 		$336K Buy
+167
New +$359K 0.46% 75
2021
Q1 		– Sell
-199
Closed -$564K – 136
2020
Q4 		$564K Sell
199
-100
-33% -$239K 1.04% 43
2020
Q3 		$706K Sell
299
-7
-2% -$17.3K 1.66% 28
2020
Q2 		$729K Buy
306
+230
+303% +$538K 2.2% 22
2020
Q1 		$152K Buy
+76
New +$195K 0.6% 43

Other funds holding MBIO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return